Ning Deng

Title: Ning Deng: Innovator in Genetic Research

Introduction

Ning Deng is a prominent inventor based in Palo Alto, CA, known for his contributions to genetic research. He holds 2 patents that focus on reducing the deleterious activity of extended nucleotide repeat containing genes. His work has significant implications for understanding and potentially mitigating genetic disorders.

Latest Patents

Deng's latest patents include innovative methods for addressing the challenges posed by mutant extended nucleotide repeat containing target genes. One patent describes an enantiomeric compound that can reduce the deleterious impact of such genes in a cell. This method involves contacting the cell with an effective amount of a tetrahydrocarbazolamine compound, which can help diminish the toxicity and dysfunctionality of the products encoded by the target gene. Another patent focuses on nucleoside agents that similarly aim to reduce the harmful activity of these mutant genes. Both patents provide kits and compositions for practicing these methods, showcasing Deng's commitment to advancing genetic research.

Career Highlights

Ning Deng has worked at prestigious institutions, including Leland Stanford Junior University and National Yang Ming Chiao Tung University. His research has contributed to a deeper understanding of genetic mechanisms and potential therapeutic approaches.

Collaborations

Deng has collaborated with notable colleagues, including Stanley N. Cohen and Yanan Feng, who is a prominent female scientist in the field. These collaborations have enriched his research and expanded the impact of his work.

Conclusion

Ning Deng's innovative patents and research contributions position him as a key figure in the field of genetic research. His work not only addresses critical challenges in genetics but also paves the way for future advancements in therapeutic strategies.